CGA reduced body weight and fat deposition by possibly involving in PGC-1α and UCP1 in obesity mouse and HepG2 cells [13] and regulating fatty acid β-oxidation by activating PPARα in the liver. The gene discussed is UCP1; the disease is obesity due to melanocortin 4 receptor deficiency.